Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).
Clinical trial NCT06253923 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06253923
- Sponsor
- SHINKEI Therapeutics, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-07-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.